{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:54:24Z","timestamp":1777618464698,"version":"3.51.4"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T00:00:00Z","timestamp":1581638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2020.00039","type":"journal-article","created":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T13:24:27Z","timestamp":1581945867000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Congenital Generalized Lipoatrophy (Berardinelli-Seip Syndrome) Type 1: Description of Novel AGPAT2 Homozygous Variants Showing the Highly Heterogeneous Presentation of the Disease"],"prefix":"10.3389","volume":"11","author":[{"given":"Giovanni","family":"Ceccarini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Magno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Pelosini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Rita","family":"Sessa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaia","family":"Scabia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margherita","family":"Maffei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"J\u00e9ru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Lascols","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corinne","family":"Vigouroux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferruccio","family":"Santini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,2,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1210\/jcem-14-2-193","article-title":"An undiagnosed endocrinometabolic syndrome: report of 2 cases","volume":"14","author":"Berardinelli","year":"1954","journal-title":"J Clin Endocrinol Metab"},{"key":"B2","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/j.1651-2227.1959.tb17558.x","article-title":"Lipodystrophy and gigantism with associated endocrine manifestations. A new diencephalic syndrome?","volume":"48","author":"Seip","year":"1959","journal-title":"Acta Paediatr Scand"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1056\/NEJMra025261","article-title":"Acquired and inherited lipodystrophies","volume":"350","author":"Garg","year":"2004","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1210\/jc.2011-1159","article-title":"Lipodystrophies: genetic and acquired body fat disorders","volume":"96","author":"Garg","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000316893","article-title":"Human lipodystrophies: genetic and acquired diseases of adipose tissue","volume":"19","author":"Capeau","year":"2010","journal-title":"Endocr Dev"},{"key":"B6","doi-asserted-by":"publisher","first-page":"5433","DOI":"10.1210\/jc.2003-030835","article-title":"Phenotypic heterogeneity in body fat distribution in patients with congenital generalized lipodystrophy caused by mutations in the AGPAT2 or seipin genes","volume":"88","author":"Simha","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"key":"B7","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s11892-018-1099-9","article-title":"Phenotypic and genetic characteristics of lipodystrophy: pathophysiology, metabolic abnormalities, and comorbidities","volume":"18","author":"Akinci","year":"2018","journal-title":"Curr Diab Rep"},{"key":"B8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1530\/endoabs.56.S20.3","article-title":"Diagnosis and treatment of lipodystrophy: a step-by-step approach","volume":"42","author":"Ara\u00fajo-Vilar","year":"2018","journal-title":"J Endocrinol Invest"},{"key":"B9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/ng880","article-title":"AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34","volume":"31","author":"Agarwal","year":"2002","journal-title":"Nat Genet"},{"key":"B10","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/ng585","article-title":"Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13","volume":"28","author":"Magr\u00e9","year":"2001","journal-title":"Nat Genet."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1210\/jc.2007-1328","article-title":"Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-Seip congenital lipodystrophy","volume":"93","author":"Kim","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1172\/JCI38660","article-title":"Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy","volume":"119","author":"Hayashi","year":"2009","journal-title":"J Clin Invest"},{"key":"B13","doi-asserted-by":"publisher","first-page":"S46","DOI":"10.1194\/jlr.R800035-JLR200","article-title":"Recent progress on acyl CoA: lysophospholipid acyltransferase research","volume":"50","author":"Shindou","year":"2009","journal-title":"J Lipid Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.2337\/db12-0004","article-title":"Alterations in lipid signaling underlie lipodystrophy secondary to AGPAT2 mutations","volume":"61","author":"Subauste","year":"2012","journal-title":"Diabetes"},{"key":"B15","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.cmet.2009.01.002","article-title":"Molecular mechanisms of hepatic steatosis and insulin resistance in the AGPAT2 deficient mouse model of congenital generalized lipodystrophy","volume":"9","author":"Cort\u00e9s","year":"2009","journal-title":"Cell Metab"},{"key":"B16","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.ecl.2016.04.012","article-title":"Leptin and hormones: energy homeostasis","volume":"45","author":"Triantafyllou","year":"2016","journal-title":"Endocrinol Metab Clin North Am."},{"key":"B17","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2147\/DMSO.S130810","article-title":"Estimating the prevalence of generalized and partial lipodystrophy: findings and challenges","volume":"10","author":"Chiquette","year":"2017","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B18","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13098-017-0280-7","article-title":"High prevalence of Berardinelli-Seip Congenital Lipodystrophy in Rio Grande do Norte State, Northeast Brazil","volume":"9","author":"De Azevedo Medeiros","year":"2017","journal-title":"Diabetol Metab Syndr"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.2337\/diabetes.52.6.1573","article-title":"Prevalence of mutations in AGPAT2 among human lipodystrophies","volume":"52","author":"Magr\u00e9","year":"2003","journal-title":"Diabetes"},{"key":"B20","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/ijo.2011.243","article-title":"Hepatic left lobe volume is a sensitive index of metabolic improvement in obese women after gastric banding","volume":"36","author":"Giannetti","year":"2012","journal-title":"Int J Obes"},{"key":"B21","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1146\/annurev.genom.7.080505.115715","article-title":"Genetic disorders of adipose tissue development, differentiation, and death","volume":"7","author":"Agarwal","year":"2006","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"B22","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.ejmg.2012.07.011","article-title":"Identification of a novel nonsense mutation and a missense substitution in the AGPAT2 gene causing congenital generalized lipodystrophy type 1","volume":"55","author":"Haghighi","year":"2012","journal-title":"Eur J Med Genet"},{"key":"B23","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/978-3-642-35518-9_196","article-title":"Identification and characterisation of a novel pathogenic mutation in the human lipodystrophy gene AGPAT2: C48R: a novel mutation in AGPAT2","volume":"9","author":"Ramanathan","year":"2013","journal-title":"JIMD Rep"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1210\/jc.2016-1005","article-title":"Natural history of congenital generalized lipodystrophy: a nationwide study from Turkey","volume":"101","author":"Akinci","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"key":"B25","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s13410-012-0099-6","article-title":"Berardinelli Seip congenital lipodystrophy presenting with neonatal diabetes mellitus due to a mutation in the AGPAT2 gene","volume":"33","author":"Poovazhagi","year":"2013","journal-title":"Int J Diabetes Dev C."},{"key":"B26","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1399-0004.2012.01939.x","article-title":"Clinical and molecular characterization of neonatal diabetes and monogenic syndromic diabetes in Asian Indian children","volume":"83","author":"Jahnavi","year":"2013","journal-title":"Clin Genet."},{"key":"B27","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.bbrc.2004.12.024","article-title":"Enzymatic activity of naturally occurring 1-acylglycerol-3-phosphate-O-acyltransferase 2 mutants associated with congenital generalized lipodystrophy","volume":"327","author":"Haque","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"B28","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/cge.12623","article-title":"Congenital generalized lipodystrophy: identification of novel variants and expansion of clinical spectrum","volume":"89","author":"Haghighi","year":"2016","journal-title":"Clin Genet."},{"key":"B29","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.ymgme.2013.04.011","article-title":"Early infantile cardiomyopathy and liver disease: a multisystemic disorder caused by congenital lipodystrophy","volume":"109","author":"Debray","year":"2013","journal-title":"Mol Genet Metab"},{"key":"B30","doi-asserted-by":"publisher","first-page":"4840","DOI":"10.1210\/jc.2003-030855","article-title":"Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy","volume":"88","author":"Agarwal","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e87173","DOI":"10.1371\/journal.pone.0087173","article-title":"Divergent metabolic phenotype between two sisters with congenital generalized lipodystrophy due to double AGPAT2 homozygous mutations. a clinical, genetic and in silico study","volume":"9","author":"Cort\u00e9s","year":"2014","journal-title":"PLoS ONE"},{"key":"B32","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/j.1365-2265.2009.03532.x","article-title":"Novel mutations of the BSCL2 and AGPAT2 genes in 10 families with Berardinelli-Seip congenital generalized lipodystrophy syndrome","volume":"71","author":"Miranda","year":"2009","journal-title":"Clin Endocrinol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00592-011-0308-7","article-title":"Description of an AGPAT2 pathologic allelic variant in a 54-year-old Caucasian woman with Berardinelli-Seip syndrome","volume":"48","author":"Pelosini","year":"2011","journal-title":"Acta Diabetol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.arcped.2008.10.005","article-title":"Congenital generalized lipodystrophy: a case report with neurological involvement","volume":"16","author":"Ben Turkia","year":"2009","journal-title":"Arch Pediatr"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1007\/s00256-016-2457-9","article-title":"Bone imaging findings in genetic and acquired lipodystrophic syndromes: an imaging study of 24 cases","volume":"45","author":"Teboul-Cor\u00e9","year":"2016","journal-title":"Skeletal Radiol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ando.2012.11.008","article-title":"AGPAT2 gene mutation in a child with Berardinelli-Seip congenital lipodystrophy syndrome","volume":"74","author":"Rostami","year":"2013","journal-title":"Ann Endocrinol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1210\/jc.2003-030485","article-title":"Mutations in Gng3lg and AGPAT2 in Berardinelli-Seip congenital lipodystrophy and Brunzell syndrome: phenotype variability suggests important modifier effects","volume":"89","author":"Fu","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B38","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12872-017-0738-4","article-title":"Early commitment of cardiovascular autonomic modulation in Brazilian patients with congenital generalized lipodystrophy","volume":"18","author":"Ponte","year":"2018","journal-title":"BMC Cardiovasc Disord"},{"key":"B39","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1210\/jc.2003-030415","article-title":"Mutations in the seipin and AGPAT2 genes clustering in consanguineous families with Berardinelli-Seip congenital lipodystrophy from two separate geographical regions of Brazil","volume":"89","author":"Gomes","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B40","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1590\/S0004-27302011000100007","article-title":"Genetic and metabolic description of five patients with Berardinelli-Seip syndrome","volume":"55","author":"Barra","year":"2011","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"319","DOI":"10.4274\/jcrpe.0227","article-title":"A Patient with Berardinelli-Seip Syndrome, novel AGPAT2 splicesite mutation and concomitant development of non-diabetic polyneuropathy","volume":"11","author":"Oswiecimska","year":"2018","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"164","DOI":"10.21767\/AMJ.2016.2640","article-title":"A novel variant of the AGPAT2 mutation in generalized congenital lipodystrophy, detected by next generation sequencing","volume":"9","author":"Shetty","year":"2016","journal-title":"Australas Med J."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.metabol.2008.04.008","article-title":"Energy balance in congenital generalized lipodystrophy type I","volume":"57","author":"Taleban","year":"2008","journal-title":"Metabolism"},{"key":"B44","doi-asserted-by":"publisher","first-page":"103542","DOI":"10.1016\/j.ejmg.2018.09.009","article-title":"Further delineation of AGPAT2 and BSCL2 related congenital generalized lipodystrophy in young infants","volume":"62","author":"Liu","year":"2018","journal-title":"Eur J Med Genet"},{"key":"B45","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/MD.0b013e3181e9442f","article-title":"Cardiomyopathy in congenital and acquired generalized lipodystrophy: a clinical assessment","volume":"89","author":"Lupsa","year":"2010","journal-title":"Medicine."},{"key":"B46","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.pathol.2018.11.004","article-title":"Lipodystrophies, dyslipidaemias and atherosclerotic cardiovascular disease","volume":"51","author":"Hussain","year":"2019","journal-title":"Pathology"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e0199052","DOI":"10.1371\/journal.pone.0199052","article-title":"Causes of death in patients with Berardinelli-Seip congenital generalized lipodystrophy","volume":"8","author":"Lima","year":"2018","journal-title":"PLoS ONE"},{"key":"B48","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1034\/j.1399-0004.2002.610407.x","article-title":"Cardiomyopathy in congenital complete lipodystrophy","volume":"61","author":"Bhayana","year":"2002","journal-title":"Clin Genet"},{"key":"B49","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1136\/jmg.39.10.722","article-title":"Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy","volume":"39","author":"Van Maldergem","year":"2002","journal-title":"J Med Genet"},{"key":"B50","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.mrrev.2019.03.005","article-title":"The worldwide mutational landscape of Berardinelli-Seip congenital lipodystrophy","volume":"781","author":"Craveiro Sarmento","year":"2019","journal-title":"Mutat Res."}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2020.00039\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T13:24:30Z","timestamp":1581945870000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2020.00039\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,14]]},"references-count":50,"alternative-id":["10.3389\/fendo.2020.00039"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2020.00039","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,14]]},"article-number":"39"}}